CDKN2A and osteosarcoma: In fact, in our cellular models (U2OS osteosarcoma cells and A549 lung adenocarcinoma cells), both of which are deficient in p16 INK4A, the cells maintained a proper state of senescence after treatment with cisplatin along the days, even reaching truly long-lasting periods of time.